Company: DERM
Filing Date: 2025-08-28
Form Type: 424B3
Source: 0001104659-25-084876
Chunk: 20

Company: Journey Medical Corp
Filing Date: 2025-08-28
Form: 424B3
Chunk 20
---
 any such instruction. We or the Agents may suspend the offering
of our common stock being made through the Agents under the Sales Agreement upon proper notice to the other party. We have the right,
by giving written notice as specified in the Sales Agreement, to terminate the Sales Agreement in our sole discretion at any time. Each
Agent has the right, by giving written notice as specified in the Sales Agreement, to terminate the Sales Agreement, solely as to such
Agent, in its sole discretion, at any time.

The aggregate compensation payable to each Agent is equal to 3.0% of
the gross sales price of the shares sold through such Agent pursuant to the Sales Agreement. We have also agreed to reimburse the Agents
up to $75,000 of the Agents’ actual outside legal expenses incurred by the Agents in connection with this offering. We have also
agreed to reimburse the Agents for certain ongoing expenses not to exceed $7,500 per quarter in connection with updates to the offering
at the time of Representation Dates, as defined in the Sales Agreement. We estimate that the total expenses of the offering payable by
us, excluding commissions payable to the Agents under the Sales Agreement, will be approximately $225,000.

The remaining sales proceeds, after deducting
any expenses payable by us and any transaction fees imposed by any governmental, regulatory, or self-regulatory organization in connection
with the sales, will equal our net proceeds for the sale of such common stock.

Each of the Agents will provide written confirmation
to us following the close of trading on the on each day in which common stock is sold through it as sales agent under the Sales Agreement.
Each confirmation will include the number of shares of common stock sold through it as sales agent on that day, the volume weighted average
price of the shares sold, the percentage of the daily trading volume and the net proceeds to us.

We will report at least quarterly the number of
shares of common stock sold through the Agents under the Sales Agreement, the net proceeds to us and the compensation paid by us to the
Agents in connection with the sales of common stock.

Settlement for sales of common stock will occur,
unless the parties agree otherwise or otherwise required by law, on the first business day that is also a trading day following the date
on which any sales were made in return for payment of the net proceeds to us. There is no arrangement for funds to be received in an escrow,
trust or similar arrangement.

In connection with the sales of our common stock
on our